COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
Authors
Keywords
-
Journal
Clinical Interventions in Aging
Volume Volume 15, Issue -, Pages 1231-1240
Publisher
Informa UK Limited
Online
2020-07-21
DOI
10.2147/cia.s261516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission
- (2020) Jinyang Gu et al. GASTROENTEROLOGY
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period
- (2020) Ping Yu et al. JOURNAL OF INFECTIOUS DISEASES
- Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2
- (2020) Zhixin Liu et al. JOURNAL OF MEDICAL VIROLOGY
- The global epidemiology of hypertension
- (2020) Katherine T. Mills et al. Nature Reviews Nephrology
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
- (2020) Yanan Cao et al. Cell Discovery
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice
- (2020) Guogang Xu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
- (2020) Daniel Batlle et al. CLINICAL SCIENCE
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
- (2020) Joseph T. Wu et al. NATURE MEDICINE
- ADAM17 inhibition may exert a protective effect on COVID-19
- (2020) Vanesa Palau et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
- (2020) Rami Sommerstein et al. Journal of the American Heart Association
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective
- (2020) Thea Magrone et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- COVID-19, MERS and SARS with Concomitant Liver Injury—Systematic Review of the Existing Literature
- (2020) Michał Kukla et al. Journal of Clinical Medicine
- The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
- (2020) Joris R. Delanghe et al. CLINICA CHIMICA ACTA
- COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
- (2020) Florian Zores et al. Frontiers in Cardiovascular Medicine
- Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism
- (2019) Zhimin Fan et al. LIFE SCIENCES
- Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
- (2019) Peter Serfozo et al. HYPERTENSION
- Severe Acute Respiratory Syndrome
- (2019) David S.C. Hui et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- The Association Between ACE2 Gene Polymorphism and the Stroke Recurrence in Chinese Population
- (2018) Xiaomei Wu et al. Journal of Stroke & Cerebrovascular Diseases
- 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
- (2018) Yizhi Pan et al. Lipids in Health and Disease
- Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender
- (2018) Qi Zhang et al. MEDICINE
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites
- (2017) Y. Y. Chen et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
- (2017) Xiao C. Li et al. PHARMACOLOGICAL RESEARCH
- Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors
- (2016) Y Y Chen et al. JOURNAL OF HUMAN HYPERTENSION
- Association between circulating levels of ACE2-Ang-(1–7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients
- (2016) Dan Liu et al. MEDICINE
- Adherencia terapéutica en la enfermedad crónica: estado de la situación y perspectiva de futuro
- (2014) P. Conthe et al. REVISTA CLINICA ESPANOLA
- The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents
- (2013) Lucile Malard et al. BMC Medical Genetics
- TheACE2gene: its potential as a functional candidate for cardiovascular disease
- (2012) Louise M. Burrell et al. CLINICAL SCIENCE
- ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects
- (2012) Na Lu et al. MOLECULAR BIOLOGY REPORTS
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
- A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project
- (2011) Ciara Vangjeli et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
- (2010) Yumiko Imai et al. CIRCULATION JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started